Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
L.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.339NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.229NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.415NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.370NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.421NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.612NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.305NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.32.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBDNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BG.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.576NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.325NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.521NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.378NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.206NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.53 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.599NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.128NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.451NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.313NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.609NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used